Floatz logo

Strattera

Freezing of Gait

Radboud University Medical CenterPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Freezing of Gait cohort.

Asset / SponsorPhaseRating
Vortioxetine
Marianna Amboni
Phase 4BB
Amantadine
Seoul National University Hospital
Phase 4B
Droxidopa
Henry Ford Health System
Phase 2CCC

Same molecule, other indications

Strattera is also rated in:

Parkinson diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
depressive disorderDormant
BB
Indicative ·
69 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →